4DMedical Ltd.ASX: 4DX

AGM Presentation and Chair's address

· Issued by 4DMedical Ltd. via ASX

Filed with ASX · · 40 pages · English

Summary by 6ix AI

It includes highlights of the company's achievements, such as FDA clearance for its CT:VQ® product and expansion into international markets. The document outlines the company's operational performance, including revenue growth and increased scan deliveries, reflecting its market position in respiratory imaging.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/agm-presentation-and-chairs-address

Release

ASX announcement ASX:4DX Presentation and Chair’s address to the 2026 Annual General Meeting 28 October 2026 Melbourne, Australia, 28 October 2026: 4DMedical Limited (ASX: 4DX, “4DMedical” or the “Company”) attaches the following materials to be presented at the Annual General Meeting of...

4DMedical Ltd. on 6ix

In the deck

Story so far

Earlier from 4DMedical

Later from 4DMedical

All 4DMedical news releases